CMS Wants To Help With Medicaid Outcomes-Based Reimbursement For Cell And Gene Therapy

Center for Medicare and Medicaid Innovation (CMMI) deputy director Ellen Lukens talked about the goals and challenges of a new voluntary program the agency will test with state Medicaid programs.

The US Centers for Medicare and Medicaid Services (CMS) is optimistic that a new voluntary program it expects to launch in 2025 that could help pave the way for broader access to expensive cell and gene therapies under Medicaid, while also saving the government money.

Center for Medicare and Medicaid Innovation (CMMI) deputy director Ellen Lukens discussed some of the goals of the program –...